Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.GUILFORD,...
VANCOUVER, Washington, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Dear Shareholders, As I look back on 2024, during which CytoDyn Inc....
FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review...
EYLEA HD demonstrated non-inferior vision gains with an every 8-week dosing regimen compared to EYLEA® (aflibercept) Injection 2 mg dosed...
NEW YORK, Dec. 15, 2024 /PRNewswire/ -- The global online therapy services market size is estimated to grow by USD 16.16 billion...
Pre-Money Valuation of JPY9 Billion is Approximately Multiples of Current Parent Company Market Capitalization.Strategic Investors Further Validation of Technology and...
The report from The Insight Partners lists several stakeholders—including healthcare providers, government agencies and health authorities, insurance providers, and academic...
SEATTLE, WA / ACCESSWIRE / December 12, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology...
MIAMI, Dec. 12, 2024 /PRNewswire/ -- Healthy Together, a leading provider of cloud-based Software-as-a-Service (SaaS) solutions, has announced its expanded...
-- New research demonstrates integrating AI-enabled, health record data insights with targeted educational interventions can enhance understanding and management of...
Two of three patients achieved both complete remission and MRD-negative statusHigh response rates observed in earlier studies continue in ongoing...
OCALA, Fla., Dec. 12, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that...
PALO ALTO, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative...
Presentations complement topline data with new data from two pivotal studies (Studies 501 and 502) evaluating lumateperone as an adjunctive...
Incumbent Board’s Claims of Progress Are Not Credible or Supported by DataAIM Maintains Relationship with CRO Co-Founded by a Convicted...
Extensive Scientific Evidence Supporting Growth Factor Receptor Bound Protein-2 (Grb2) as Fundamental Link in Insulin Resistance Reallocates Resources to Metabolic...
Based on more than six months of additional monitoring, data show continued improvement in overall survival (OS) in intent-to-treat (ITT)...
Sales Focus Inc., the sales outsourcing pioneer, has released a comprehensive white paper, "How to Thrive in the Era of Virtual...
FORT LAUDERDALE, FL / ACCESSWIRE / December 9, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering...
WARRINGTON, Pa., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company...